Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil citrate for analgesia in invasively mechanically ventilated ICU patients
ChiCTR2500102757Phase 2Not yet recruiting
- Sponsor
- Union Hospital
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sufentanil in pain (3 arms), sponsored by Union Hospital. Primary endpoints: Proportion of time at target analgesia and sedation level, Plasma concentration and pharmacokinetic parameters and 5 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
pain
Beyond the preview
Go deeper on ChiCTR2500102757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102757.